Literature DB >> 6707212

Human Protein Z.

G J Broze, J P Miletich.   

Abstract

Protein Z was purified from human plasma by a four-step procedure which included barium citrate adsorption, ammonium sulfate fractionation, DEAE-Sepharose chromatography, and blue agarose chromatography with a yield of 20%. It is a 62,000 mol wt protein with an extinction coefficient of 12.0. The concentration of Protein Z in pooled, citrated plasma is 2.2 micrograms/ml and its half-life in patients starting warfarin anticoagulation therapy is estimated to be less than 2.5 d. The NH2-terminal sequence is Ala-Gly-Ser-Tyr-Leu-Leu-(Gla)-(Gla)-Leu-Phe-(Gla)-Gly-Asn-Leu. Neither Protein Z nor its cleavage products, which were obtained by treatment of Protein Z with thrombin or plasmin, incorporated [3H]diisopropyl fluorophosphate. The physiological function of Protein Z remains unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707212      PMCID: PMC425104          DOI: 10.1172/JCI111317

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin.

Authors:  C T Esmon; J W Suttie; C M Jackson
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

2.  Rabbit plasminogen and plasmin isozymes.

Authors:  F J Castellino; J M Sodetz
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

3.  A form of bovine factor X with a single polypeptide chain.

Authors:  P Mattock; M P Esnouf
Journal:  Nat New Biol       Date:  1973-03-21

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Measurement of protein concentration with interferences optics.

Authors:  J Babul; E Stellwagen
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin.

Authors:  G L Nelsestuen; T H Zytkovicz; J B Howard
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  Vitamin K dependent modifications of glutamic acid residues in prothrombin.

Authors:  J Stenflo; P Fernlund; W Egan; P Roepstorff
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

View more
  29 in total

1.  Prothrombotic phenotype of protein Z deficiency.

Authors:  Z F Yin; Z F Huang; J Cui; R Fiehler; N Lasky; D Ginsburg; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor.

Authors:  Juan Pedro Kusanovic; Jimmy Espinoza; Roberto Romero; Debra Hoppensteadt; Jyh Kae Nien; Chong Jai Kim; Offer Erez; Eleazar Soto; Jawed Fareed; Sam Edwin; Tinnakorn Chaiwerapongsa; Nador G Than; Bo Hyun Yoon; Ricardo Gomez; Zoltan Papp; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-06

Review 3.  A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; George Broze; Sandra Fedi
Journal:  Thromb Haemost       Date:  2010-01-13       Impact factor: 5.249

4.  Low protein Z plasma level is a risk factor for acute myocardial infarction in coronary atherosclerosis disease patients.

Authors:  Baoxin Liu; Yong Li; Jiachen Luo; Liming Dai; Jinlong Zhao; Hongqiang Li; Qiqiang Jie; Dongzhi Wang; Xin Huang; Yidong Wei
Journal:  Thromb Res       Date:  2016-10-13       Impact factor: 3.944

5.  Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Authors:  T J Girard; N M Lasky; K Grunz; G J Broze
Journal:  J Thromb Haemost       Date:  2018-12-16       Impact factor: 5.824

6.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

7.  Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.

Authors:  Jing Zhang; Yizheng Tu; Lan Lu; Nina Lasky; George J Broze
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

8.  Low plasma protein Z levels in patients with ischemic colitis.

Authors:  Ioannis E Koutroubakis; Angeliki Theodoropoulou; Aekaterini Sfiridaki; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

9.  Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.

Authors:  Xin Huang; Richard Swanson; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

10.  Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Ioannis Asproudis; Taxiarchis L Felekis; Spiridon Gorezis; Lefkothea Dova; Eleni Dokou; Georgios Vartholomatos; Miltiadis Aspiotis; Nikolaos I Kolaitis
Journal:  Open Ophthalmol J       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.